137 related articles for article (PubMed ID: 38350499)
1. Intranasal delivery of thin-film freeze-dried monoclonal antibodies using a powder nasal spray system.
Yu YS; Xu H; AboulFotouh K; Williams G; Suman J; Sahakijpijarn S; Cano C; Warnken ZN; Wu KC; Williams RO; Cui Z
Int J Pharm; 2024 Mar; 653():123892. PubMed ID: 38350499
[TBL] [Abstract][Full Text] [Related]
2. Feasibility of intranasal delivery of thin-film freeze-dried, mucoadhesive vaccine powders.
Yu YS; AboulFotouh K; Xu H; Williams G; Suman J; Cano C; Warnken ZN; Wu KC; Williams RO; Cui Z
Int J Pharm; 2023 Jun; 640():122990. PubMed ID: 37127138
[TBL] [Abstract][Full Text] [Related]
3. Dry powders for inhalation containing monoclonal antibodies made by thin-film freeze-drying.
Hufnagel S; Xu H; Sahakijpijarn S; Moon C; Chow LQM; Williams Iii RO; Cui Z
Int J Pharm; 2022 Apr; 618():121637. PubMed ID: 35259440
[TBL] [Abstract][Full Text] [Related]
4. Dual targeting powder formulation of antiviral agent for customizable nasal and lung deposition profile through single intranasal administration.
Seow HC; Liao Q; Lau ATY; Leung SWS; Yuan S; Lam JKW
Int J Pharm; 2022 May; 619():121704. PubMed ID: 35358643
[TBL] [Abstract][Full Text] [Related]
5. Development of favipiravir dry powders for intranasal delivery: An integrated cocrystal and particle engineering approach via spray freeze drying.
Wong SN; Li S; Low KH; Chan HW; Zhang X; Chow S; Hui B; Chow PCY; Chow SF
Int J Pharm; 2024 Mar; 653():123896. PubMed ID: 38346602
[TBL] [Abstract][Full Text] [Related]
6. Manufacturing of High-Concentration Monoclonal Antibody Formulations via Spray Drying-the Road to Manufacturing Scale.
Gikanga B; Turok R; Hui A; Bowen M; Stauch OB; Maa YF
PDA J Pharm Sci Technol; 2015; 69(1):59-73. PubMed ID: 25691715
[TBL] [Abstract][Full Text] [Related]
7. Neutralisation of SARS-CoV-2 by monoclonal antibody through dual targeting powder formulation.
Seow HC; Cai JP; Pan HW; Luo C; Wen K; Situ J; Wang K; Cao H; Leung SWS; Yuan S; Lam JKW
J Control Release; 2023 Jun; 358():128-141. PubMed ID: 37084889
[TBL] [Abstract][Full Text] [Related]
8. Spray-Dried and Spray-Freeze-Dried Powder Formulations of an Anti-Interleukin-4Rα Antibody for Pulmonary Delivery.
Pan HW; Seow HC; Lo JCK; Guo J; Zhu L; Leung SWS; Zhang C; Lam JKW
Pharm Res; 2022 Sep; 39(9):2291-2304. PubMed ID: 35879500
[TBL] [Abstract][Full Text] [Related]
9. Influence of deposition and spray pattern of nasal powders on insulin bioavailability.
Pringels E; Callens C; Vervaet C; Dumont F; Slegers G; Foreman P; Remon JP
Int J Pharm; 2006 Mar; 310(1-2):1-7. PubMed ID: 16427222
[TBL] [Abstract][Full Text] [Related]
10. Design, characterization, and aerosol dispersion performance modeling of advanced spray-dried microparticulate/nanoparticulate mannitol powders for targeted pulmonary delivery as dry powder inhalers.
Li X; Vogt FG; Hayes D; Mansour HM
J Aerosol Med Pulm Drug Deliv; 2014 Apr; 27(2):81-93. PubMed ID: 24502451
[TBL] [Abstract][Full Text] [Related]
11. Inhalable dry powders of microRNA-laden extracellular vesicles prepared by thin-film freeze-drying.
AboulFotouh K; Almanza G; Yu YS; Joyce R; Davenport GJ; Cano C; Williams Iii RO; Zanetti M; Cui Z
Int J Pharm; 2024 Feb; 651():123757. PubMed ID: 38160992
[TBL] [Abstract][Full Text] [Related]
12. Identification of Stability Constraints in the Particle Engineering of an Inhaled Monoclonal Antibody Dried Powder.
Brunaugh AD; Ding L; Wu T; Schneider M; Khalaf R; Smyth HDC
J Pharm Sci; 2022 Feb; 111(2):403-416. PubMed ID: 34453927
[TBL] [Abstract][Full Text] [Related]
13. Development and testing of particulate formulations for the nasal delivery of antibodies.
Kaye RS; Purewal TS; Alpar OH
J Control Release; 2009 Apr; 135(2):127-35. PubMed ID: 19059291
[TBL] [Abstract][Full Text] [Related]
14. Protein inhalation powders: spray drying vs spray freeze drying.
Maa YF; Nguyen PA; Sweeney T; Shire SJ; Hsu CC
Pharm Res; 1999 Feb; 16(2):249-54. PubMed ID: 10100310
[TBL] [Abstract][Full Text] [Related]
15. Micro-fluidic Spray Freeze Dried Ciprofloxacin Hydrochloride-Embedded Dry Powder for Inhalation.
Chen Y; Yan S; Zhang S; Yin Q; Chen XD; Wu WD
AAPS PharmSciTech; 2022 Aug; 23(6):211. PubMed ID: 35915199
[TBL] [Abstract][Full Text] [Related]
16. Porous and highly dispersible voriconazole dry powders produced by spray freeze drying for pulmonary delivery with efficient lung deposition.
Liao Q; Yip L; Chow MYT; Chow SF; Chan HK; Kwok PCL; Lam JKW
Int J Pharm; 2019 Apr; 560():144-154. PubMed ID: 30731259
[TBL] [Abstract][Full Text] [Related]
17. Pharmaceutical dry powders of small molecules prepared by thin-film freezing and their applications - A focus on the physical and aerosol properties of the powders.
Praphawatvet T; Cui Z; Williams RO
Int J Pharm; 2022 Dec; 629():122357. PubMed ID: 36332829
[TBL] [Abstract][Full Text] [Related]
18. Spray freeze drying for dry powder inhalation of nanoparticles.
Ali ME; Lamprecht A
Eur J Pharm Biopharm; 2014 Aug; 87(3):510-7. PubMed ID: 24657824
[TBL] [Abstract][Full Text] [Related]
19. Development of drug alone and carrier-based GLP-1 dry powder inhaler formulations.
Babenko M; Alany RG; Calabrese G; Kaialy W; ElShaer A
Int J Pharm; 2022 Apr; 617():121601. PubMed ID: 35181460
[TBL] [Abstract][Full Text] [Related]
20. Effect of Particle Formation Process on Characteristics and Aerosol Performance of Respirable Protein Powders.
Brunaugh AD; Wu T; Kanapuram SR; Smyth HDC
Mol Pharm; 2019 Oct; 16(10):4165-4180. PubMed ID: 31448924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
